ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994

Breast Cancer action Plan Calls For More federal Coordination, Patient Participation

March 23, 1994

In Brief: Coalition Dinner Celebrates NCI’s 50th Anniversary, Honors Lasker, Three Ex-Senators

September 18, 1987

ASCO Special Awards Honor Oncology Leaders.

April 2, 2010

Ohio Judge Fines CareToLive Prostate Cancer Group That Sought The Cancer Letter’s Confidential Source Material On Provenge.

February 29, 2008

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012